any patients receive cytotoxic therapies that result in complications to the oral mucosa. Other patients receive either radiation or surgery as treatment of malignancies involving the head and neck region, with resultant consequences to the normal structures of the oral cavity and pharynx.Strategies for managing these sequelae of therapy include a combination of preventive measures, treatment directed at reversal of the insults to the oral tissues, and supportive care interventions. Few objective scales on oral morbidity have been reliably evaluated in clinical measure studies.
General ConsiderationsOverview Evaluation, treatment, and prevention of any oral and dental preexisting pathology is an important aspect of the overall treatment outcome for cancer patients. 1,2 Patients undergoing aggressive anticancer treatment encounter preventable, if not treatable, oral mucosal and dental sequelae that could produce morbid events. 3 Complications vary with each patient, depending on the individual's oral and dental status, the type of malignancy, and the therapeutic approach (i.e., surgery, radiation therapy, chemotherapy, or a combination of these treatments). 4 Oral complications associated with cancer therapy can be classified into seven general types: stomatitis, infection, bleeding, mucositis, pain, loss of function, and xerostomia. 5 Such complications arise primarily in three anatomic sites: the mucosa, periodontium, and teeth. 4 Management algorithms for these complications are reviewed in the following sections dedicated to the causative modalities.